Synthesis of unnatural amino acids from serine derivatives by β-fragmentation of primary alkoxyl radicals

Journal of Organic Chemistry

Volumn 72, Issue 19, 2007, Pages 7260-7269

  Boto, Alicia ^a   Gallardo, Juan A ^a   Hernández, Dácil ^a   Hernández, Rosendo ^a  

^a INSTITUTO DE PRODUCTOS NATURALES Y AGROBIOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATION; DERIVATIVES; FREE RADICALS; OXIDATION; REACTION KINETICS; SYNTHESIS (CHEMICAL);

ALLYLATION; ARYLATION; PEPTIDOMIMETICS;

AMINO ACIDS;

AMINO ACID DERIVATIVE; RADICAL; SERINE DERIVATIVE;

ALKYLATION; ALLYLATION; AMINO ACID SYNTHESIS; ARTICLE; ARYLATION; ONE POT SYNTHESIS; REACTION ANALYSIS;

ALCOHOLS; ALKYLATION; AMINO ACIDS; FREE RADICALS; SERINE;

EID: 34548810219     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo071155t     Document Type: Article

References (80)

1. For reviews on the synthetic and therapeutic use of nonproteinogenic amino acids, see: (a) Bridges, R. J.; Esselinger, C. S. Pharmacol. Ther. 2005, 107, 271-285.
2. (b) Van Bambeke, F. Curr. Opin. Pharmacol. 2004, 4, 471-478.
3. (c) Johansen. T. N.; Greenwood, J. R.; Frydenvang, K.; Madsen, U.; Krogsgaard-Larsen, P. Chirality 2003, 15, 167-179.
4. (d) Beck, G. Synlett 2002, 837-850.
5. (e) Nájera, C. Synlett 2002, 1388-1403.
6. (f) Sardina, F. J.; Rapoport. H. Chem. Rev. 1996, 96, 1825-1872.
7. Bhide, R.; Mortezaei, R.; Scilimati, A.; Sih, C. J. Tetrahedron Lett. 1990, 31, 4827-4830.
8. Kawasaki, T.; Enoki, H.; Matsumura, K.; Ohyama, M.; Inagawa, M.; Sakamoto. M. Org. Lett. 2000, 2, 3027-3029.
9. (a) For reviews, see: Pace, J. L.; Yang, G. Biochem. Pharmacol. 2006, 71, 968-980.
10. (b) Walker, S.; Chen, L.; Hu, Y.; Rew, Y.; Shin, D.; Boger, D. L. Chem. Rev. 2005, 105, 449-475.
11. (c) Welzel, P. Chem. Rev. 2005, 105, 4610-4660.
12. (d) Kahne, D.; Leimkuhler, C.; Lu, W.; Walsh, C. Chem. Rev. 2005, 105, 425-448.
13. (a) Morín, R. B.; Gorman, M. Chemistry and Biology of β-Lactam Antibiotics, Vols. 1-3; Academic: New York, 1982.
14. (b) Townsend, C. A.; Brown, A. M. J. Am. Chem. Soc. 1983, 105, 913-918.
15. Moloney, M. G. Nat. Prod. Rep. 1999, 16, 485-498.
16. (a) Chen, K. X.; Njoroge, F. G.; Arasappan, A.; Venkatraman, S.; Vibulbhan, B.; Yang, W.; Parekh, T. N.; Pichardo, J.; Prongay, A.; Cheng, K. C.; Butkiewicz, N.; Yao, N.; Madison, V.; Girijavallabhan, V. J. Med. Chem. 2006, 49, 995-1005.
17. (b) Sollis, S. L. J. Org. Chem. 2005, 70, 4735-4740.
18. (c) Stilz, H. U.; Guba, W.; Jablonka, B.; Just, M.; Klinger, O.; König, W.; Wehner, V.; Zoller, G. J. Med. Chem. 2001, 44, 1158-1176.
19. (a) For some reviews, see: Sewald, N.; Jakubke, H. D. Peptides: Chemistry and Biology; Wiley-VCH: Weinheim, 2002.
20. (b) Liskamp, R. M. J. Angew. Chem., Int. Ed. Engl. 1994, 33, 305-307.
21. (c) Gante, J. Angew. Chem., Int. Ed. Engl. 1994, 33, 1699-1720.
22. (d) Giannis, A.; Kolter, T. Angew. Chem., Int. Ed. Engl. 1993, 32, 1244-1267.
23. Over 30 new amino acids have been genetically encoded, see: Wang, L.; Schultz, P. G. Angew. Chem., Int. Ed. 2005, 44, 34-66.
24. For some reviews, see: (a) Viso, A.; Fernández de la Pradilla, R.; García, A.; Flores, A. Chem. Rev. 2005, 105, 3167-3196.
25. (b) O'Donnell, M. J. Acc. Chem. Res. 2004, 37, 506-517.
26. (c) Erdik, E. Tetrahedron 2004, 60, 8747-8782.
27. (d) Taggi, A. E.; Hafez, A. M.; Lectka, T. Acc. Chem. Res. 2003, 36, 10-19.
28. (e) Ma, J.-A. Angew. Chem., Int. Ed. 2003, 42, 4290-4299.
29. (f) Maruoka, K.; Ooi, T. Chem. Rev. 2003, 103, 3013-3028.
30. (h) Asymmetric Synthesis of Novel Sterically Constrained Amino Acids; Symposium-in-Print, Hruby, V. J.; Soloshonok, V. A., Eds. Tetrahedron 2001, 57, 6329-6650 and references cited therein.
31. Gröger, H. Chem. Rev. 2003, 103, 2795-2827.
32. (a) Cekovic, Z. Tetrahedron 2003, 59, 8073-8090.
33. (b) Feray, L.; Kuznetsov, N.; Renaud, P. In Radicals in Organic Synthesis; Renaud, P.; Sibi, M. P., Eds.; Wiley-VCH: Weinheim, 2001; Vol. 2; pp 246-278 and references cited therein.
34. For a preliminary communication of this work, see: Boto, A.; Hernández, R.; Montoya, A.; Suárez, E. Tetrahedron Lett. 2002, 43, 8269-8272.
35. (a) Boto, A.; Gallardo, J. A.; Hernández, R.; Saavedra, C. J. Tetrahedron Lett. 2005, 46, 7807-7811.
36. (b) Boto, A.; De León, Y.; Gallardo, J. A.; Hernández, R. Eur. J. Org. Chem. 2005, 3461-3468.
37. (c) Boto, A.; Hernández, R.; Montoya, A.; Suárez, E. Tetrahedron Lett. 2004, 45, 1559-1563.
38. (d) Boto, A.; Hernández, R.; León, Y.; Suárez, E. J. Org. Chem. 2001, 65, 7796-7803.
39. (e) Boto, A.; Hernández, R.; Suárez, E. J. Org. Chem. 2000, 64, 4930-4937.
40. (a) Maryanoff, B. E.; Zhang, H.-C.; Cohen, J. H.; Turchi, I. J.; Maryanoff, C. A. Chem. Rev. 2004, 104, 1431-1628.
41. (b) Speckamp, W. N.; Hiemstra, H. In Comprehensive Organic Synthesis; Trost, B. M.; Fleming, I. Eds.; Pergamon Press: Oxford, 1991; Vol. 2, pp 1047-1082.
42. Easton, C. J.; Ivory, A. J.; Smith, C. A. J. Chem. Soc. Perkin Trans. 2 1997, 503-507.
43. For the discussion on the reaction mechanism, see: Boto, A.; Hernández, R.; De León, Y.; Murguía, J. R.; Rodríguez-Afonso, A. Eur. J. Org. Chem. 2005, 673-682.
44. (a) Ginzel, K. D.; Brungs, P.; Steckhan, E. Tetrahedron 1989, 45, 1691-1701.
45. (b) Zoller, U.; Ben-Ishai, D. Tetrahedron 1975, 31, 863-866.
46. Easton, C. J.; Peters, S. C. Aust. J. Chem. 1994, 47, 859-868.
47. (a) Priem, G.; Rocheblave, L.; De Michelis, C.; Courcambeck, J.; Kraus, J. L. J. Chem. Soc. Perkin Trans. 1 2000, 819-824.
48. (b) Niddam, V.; Camplo, M.; Le Nguyen, D.; Chermann, J. C.; Kraus, J. L. Bioorg. Med. Chem. Lett. 1996, 6, 609-614.
49. (a) Massière, F.; Badet-Denisot, M. A.; René, L.; Badet, B. J. Am. Chem. Soc. 1997, 119, 5748-5749.
50. (b) Yaouancq, L.; Anissimova, M.; Badet-Denisot, M. A.; Badet, B. Eur. J. Org. Chem. 2002, 3573-3579.
51. (a) Easton, C. J.; Scharfbillig, I. M. J. Org. Chem. 1990, 55, 384-386.
52. (b) Tanaka, K.; Ahn, M.; Watanabe, Y.; Fuji, K. Tetrahedron: Asymmetry 1996, 7, 1771-1782.
53. (c) For related allyl glycines and their therapeutic uses, see: Alcón, M.; Moyano, A.; Pericàs, M. A.; Riera, A. Tetrahedron: Asymmetry 1999, 10, 4639-4651.
54. (d) Kazmaier, U.; Krebs, A. Angew. Chem., Int. Ed. Engl. 1995, 34, 2012-2014 and references cited therein.
55. Panday, S. K.; Griffart-Brunet, D.; Langlois, N. Tetrahedron Lett. 1994, 35, 6673-6676.
56. (a) Díez, D.; García, P.; Marcos, I. S.; Basabe, P.; Garrido, N. M.; Broughton, H. B.; Urones, J. G. Tetrahedron 2005, 61, 11641-11648.
57. (b) Lygo, B.; Andrews, B. I. Tetrahedron Lett. 2003, 44, 4499-4502.
58. (c) Golubev, A. S.; Sewald, N.; Burger, K. Tetrahedron 1996, 52, 14757-14776.
59. For a very similar product, see: Werner, R. M.; Shokek, O.; Davis, J. T. J. Org. Chem. 1997, 62, 8243-8246.
60. H 1.96 (3H, s, 2-Me) were detected.
61. (a) Theoretical coupling constants were calculated over the minimized structures for both diastereomers, by using the Karplus-Altona equation implemented in the Macromodel 7.0 program. The calculations were performed with an MMFF force field, using high-quality parameters, and repeated with an AMBER force field. Similar results were obtained in both cases.
62. 2,3 = 3.7, 7.3 Hz).
63. (c) For information on the Karplus-Altona equation, see: Haasnoot, C. A. G.; de Leeuw, F. A. A. M.; Altona, C. Tetrahedron 1980, 36, 2783-2792.
64. (d) For more information on this software, see: Mohamadi, F.; Richard, N. G. J.; Guida, W. C.; Liskamp, R.; Lipton, M.; Caufield, C.; Chang, G.; Hendrikson, T.; Stille, W. C. J. Comput. Chem. 1990, 11, 440.
65. For a review on the subject, see: Couty, F.; Evano, G.; Prim, D. Mini-Rev. Org. Chem. 2004, 1, 133-148.
66. (a) Only one example of the synthesis of 4-alkoxyazetidine carboxylic acids has been reported: Akiyama, T.; Daidouji, K.; Fuchibe, K. Org. Lett. 2003, 5, 3691-3693.
67. (b) For the preparation of other azetidine carboxylic acids, see: Morimoto, H.; Wiedemann, S. H.; Yamaguchi, A.; Harada, S.; Chen, Z.; Matsunaga, S.; Shibasaki, M. Angew. Chem., Int. Ed. 2006, 45, 3146-3150 and references cited therein.
68. Faulkner, D. J. Nat. Prod. Rep. 2002, 19, 1-48.
69. (a) Culkin, D. A.; Hartwig, J. F. Acc. Chem. Res. 2003, 36, 234-245.
70. (b) Williams, R. M.; Hendrix, J. A. Chem, Rev. 1992, 92, 889-917.
71. Bretschneider, T.; Miltz, W.; Münster, P.; Steglich, W. Tetrahedron 1988, 44, 5403-5414.
72. For related examples, see: Abbenante, G.; Bergman, D. A.; Brinkworth, R. I.; March, D. R.; Reid, R. C.; Hunt, P. A.; James, I. W.; Dancer, R. J.; Garnham, B.; Stoermer, M. L.; Fairlie, D. P. Bioorg. Med. Chem. Lett. 1996, 6, 2531-2536.
73. (a) Wang, W.; Zhang, J.; Xiong, C.; Hruby, V. J. Tetrahedron Lett. 2002, 43, 2137-2140.
74. (b) Lutz, C.; Bleicher, K. H. Tetrahedron Lett. 2002, 43, 2211-2214.
75. (c) Sammelson, R. E.; Kurth, M. J. Chem. Rev. 2001, 101, 137-202.
76. (a) Drueckhammer, D. G.; Barbas, C. F., III; Nozaki, K.; Wong, C.-H.; Wood, C. Y.; Ciufolini, M. A. J. Org. Chem. 1988, 53, 1607-1611.
77. (b) For related furan glycines in anticonvulsivant or sweetening compounds, see: Kohn, H.; Sawhney, K. N.; LeGall, P.; Conley, J. D.; Robertson, D. W.; Leander, J. D. J. Med. Chem. 1990, 33, 919-926.
78. (c) Janusz, J. M.; Young, P. A.; Blum, R. B.; Riley, C. M. J. Med. Chem. 1990, 33, 1676-1682.
79. (a) For the use of indolyl glycines as synthetic intermediates (dragmacidins and dihydrohamacanthin A synthesis), see: Kawasaki, T.; Ohno, K.; Enoki, H.; Umemoto, Y.; Sakamoto, M. Tetrahedron Lett. 2002, 43, 4245-4248.
80. (b) For other related compounds, see: Zhao, J. L.; Liu, L.; Zhang, H. B.; Wu, Y. C.; Wang, D.; Chen, Y. J. Synlett 2006, 96-100 and references cited therein.